Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carcinoembryonic antigen-related cell adhesion molecule 21 pseudogene (ENSG00000224366) is a classified pseudogene in the human genome. Pseudogenes are defined as genomic sequences that bear significant sequence similarity to known genes but are generally non-functional and do not encode active proteins due to disabling mutations or loss of regulatory elements[2][3][7]. There are no known biological, diagnostic, or therapeutic roles for this pseudogene. Occasionally, some pseudogenes exhibit regulatory RNA functions, but there is no published evidence for functional activity of this particular pseudogene. It is not tracked or annotated as a drug target, receptor, or enzyme in major human genomics or drug development resources[2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carcinoembryonic antigen-related cell adhesion molecule 21 pseudogene.